Gene-editing pioneer calls for big investment in Crispr technology
Funding needed to drive innovation and make therapies available to all, says co-discoverer Jennifer Doudna
$CRBU is expanding clinical development of CB-010 into
#autoimmunedisease
. We have received IND clearance from the
@US_FDA
for CB-010 in lupus nephritis and extrarenal lupus. More details on the GALLOP Phase 1 trial here:
#Lupus
#autoimmune
#CRISPR
Fortunate to have
@ARPA_HDirector
and
@DrewEndy
join us to kick off the first meeting of 2024 of the National Security Commission on Emerging Biotech !! 🇺🇸🧬
Inspiriting for the commissioners to hear how great a biodesigned future could be and how USG could make it happen!
We're excited to announce our acquisition of Modulus Therapeutics’ cell therapy platform assets, including their chimeric antigen receptor (CAR) and switch receptor libraries!
We're pleased to share that Ginkgo has been awarded up to $6 million from
@DARPA
to produce novel proteins to control ice in extreme cold weather environments.
Hit the 1k follower mark🥳thanks all!
- Follow 4K+ & share the best things
-
#CRISPR
advocate since day 1
- Longevity expert (9 yrs+ younger)
- Many degrees in Finance & Genetics
- Finance professional & investor
- All things
#AI
#Quantum
#UFO
Just the beginning for CRISPR!🧬
$DNA Biosecurity is a must! All it takes is one bad apple to edit a new virus and release it. This should be a trillion dollar industry today not tomorrow
In his testimony before
@committeeonccp
today,
@jrkelly
will say that it is essential the US invests in bioradar and biosecurity infrastructure for detecting biological risks.
Sometimes I feel like I am this guy but in
#biotech
😅. We are early adopters to the greatest invention on earth
#crispr
#geneediting
I have a list of all the people I can’t wait to say “I told you so!” $BEAM, $CRSP, $NTLA, $CRBU, $PRME, $DNA
We're so excited to announce that we've been awarded a 5-year contract alongside
@saponiQx
, totaling up to $31 million, to discover and develop next-generation vaccine adjuvants!
This award comes to us from Medical CBRN [Chemical, Biological, Radiological, and Nuclear] Defense
Just a friendly reminder to follow me😎🧬
I follow over 4,200 people and counting in
#CRISPR
#biotech
#Longevity
#AI
#Quantum
#Finance
#stocks
and try to share and repost the most interesting I come across so you don’t have to! But recommend following the people tagged below!!
.
@Ginkgo
CEO
@jrkelly
:
“In 2018, 35% of the world’s biologics were made in the U.S. — 7% in China.
Fast forward to 2022… the share for the U.S. had fallen from 35% to 30% — and China had more than DOUBLED.
It’s a heck of a lot easier to keep it, than to lose it.”
We're pleased to invite Christian Rommel, Ph.D., to join our Board of Directors. His extensive experience accelerating innovation and advancing drug candidates across modalities will be invaluable as we continue to advance our platform and pipeline:
Today, Beam announced the clearance of its clinical trial authorisation application by the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency for BEAM-302, an in vivo base editor, as a potential treatment for patients with alpha-1 antitrypsin deficiency.
A new frontier in the treatment of solid tumors
Explore how a nascent method for the precise production of CAR-T cells could pave the way for the next generation of cancer assassins.
#CRISPR
By building best-in-class partnerships across sectors, we can generate intelligence about emerging biothreats. A new blog post from
@wef
explains the launch of the Biothreat & Disease Surveillance Initiative, which we are thrilled to be a part of!
We’re so excited to announce our new partnership with
@Prozomix
and welcome them into the Ginkgo Technology Network!
Together, we aim to build out the production of next generation enzyme plates for active pharmaceutical ingredient (API) manufacturing.
In collaboration with Vertex Pharmaceuticals, we're pleased to share that we’ve published three new publications in The New England Journal of Medicine (NEJM) containing clinical data on the treatment for sickle cell disease and beta thalassemia.
@coachsadji
I’m 1,061 days undefeated against covid! Yet no vax, take public transportation in and out of NYC, lived with people who had covid, no mask, traveled the country many times! I have my own protocols and tapped into my genome😎
🔥 Proud to announce a
@cradlebio
+
@Ginkgo
($DNA) partnership today.
Cradle and Ginkgo will make it seamless to test Cradle-designed proteins on Ginkgo's Foundry Platform, and automatically get the data back in Cradle's platform.
More on our blog:
Free online course! 🧬🔥
Register for The Jackson Laboratory's to learn about
#CRISPR
/Cas9, transgenesis via pronuclear microinjection, and embryonic stem (ES) cell-based engineering.
#crispr
#dna
#genetics
We’re excited to announce the expansion of our strategic partnership with global healthcare leader
@novonordisk
under a framework agreement that initially is contemplated to run over five years.
@nypost
Take 5% wealthy from India and 5% wealthy from China. That is about 140 million people who are trying to move to the United States and can buy property and rent with ease. Now take 5% from every other country… the middle class is being pushed out. 😔
@CRISPRTX
will ring the Opening Bell at
@NasdaqExchange
in Times Square this morning to commemorate the first-ever approval of a CRISPR therapy and to celebrate innovation as our full pipeline advances. Tune in for the livestream here at 9:15am ET:
Someone sent me $150 by accident to my cash app. Would have loved to use it to pick up more
#crispr
stocks but kindness is worth more. I sent it back 🤝🏻 come on good karma! Now x100 my stocks 😅🧬📈
My list hit 80 followers today. It is a great way to get news from about 56 different sources all in one place. Many of them are the companies and CEOs that put out press releases along with my favorite contributors. Fell free to follow it.
Our grandparents had the opportunity to invest in land, energy, & basically anything… our parents had technology, we have the Genomic Revolution 🧬💰🧬💰🧬 we will cure diseases, fix
#globalwarming
and use it for
#space
🚀 $CRBU $BEAM $CRSP $NTLA $PRME $DNA $NVTA $VERV
Tomorrow at the H.C. Wainwright 2nd Annual Cell Therapy Conference, join $CRBU CEO Rachel Haurwitz, PhD, for a fireside chat at 11:30 am ET.
The webcast of the fireside chat can be found on our website here:
#celltherapy
#CRISPR
Ginkgo Bioworks CEO Jason Kelly talks to
@MorganLBrennan
about the company's latest deal with Google Cloud, building its own
#AI
models and how quickly it can turn this into a money making endeavor
$DNA
@Ginkgo
@jrkelly
#generativeAI
Today we're so excited to announce our new partnership with
@imagindairy
!
Together, we aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner.
Inverse Jim Cramer! Buy Signal for $CRSP
Jim Cramer when asked about $CRSP
"I like those guys, but I have no illusions. they’re losing a lot of money, and we don’t like to recommend stocks that are losing a lot of money."